Your firm must have an account to access this feature
A group of attorneys from Young Conaway Stargatt & Taylor LLP and Cooley LLP is representing artificial intelligence-powered drug company BioXcel Therapeutics Inc. in its Chapter 11 case.
Louisiana’s push to halt abortion pills by mail heads back to the Fifth Circuit after a quick trip to the U.S. Supreme Court. An entirely new panel of judges is set to take up the case.
A new program rolled out by the Trump administration that aims to decrease prescription drug prices in the U.S. has been causing consternation among drug companies, which fear the resulting pricing uncertainty could gut licensing deals that were inked long before the program was even on the horizon.
Deborah Sterling and David Holman
Recent data regarding patent filing activity and litigation in the cannabis and psychedelics markets indicates tha... (more story)
Neil Issar, Bill Morrison and Taryn McDonald
In light of the U.S. Department of Justice's decision to not prosecute Campus Eye Management under the agency's ne... (more story)
Rachel Forman, Jocelyn Wiesner and Abeba Habtemariam
The U.S. Food and Drug Administration's recent decision not to pursue enforcement action against Whoop's wearable ... (more story)
The Federal Circuit on Friday upheld a Pennsylvania federal judge's decisions clearing Globus Medical Inc. of infringing Moskowitz Family LLC spinal surgery tool patents, agreeing that language used in the pat... (more story)
There are no biosimilar drugs in development for 90% of biologic products set to lose their patent exclusivity by 2034, according to a report released Thursday by the Association for Accessible Medicines, whic... (more story)
The Federal Trade Commission, as part of its regulatory streamlining, has rescinded a Biden-era policy requiring health applications and smart devices that collect information to warn users when their medical ... (more story)
An Illinois federal judge on Tuesday refused to dismiss Walgreens and Kroger's lawsuit accusing Biogen Inc. of illegally stifling competition for its multiple sclerosis drug Tecfidera, saying they've made suff... (more story)
The active steps framework announced by the U.S. Supreme Court in its Hikma v. Amarin decision, finding that Amarin failed to plausibly allege inducement of infringement, has the potential to reshape how court... (more story)
In a thinner market for healthcare transactions, with both regulators and buyers using artificial intelligence to inspect data in great detail, the margin for error in sellers' financials and legal diligence h... (more story)
A Florida federal court order requiring hospital ratings nonprofit Leapfrog to revoke poor safety grades it issued to five hospitals owned by Tenet Healthcare Corp. violated the First Amendment, Leapfrog told ... (more story)
Apple Inc. has told the U.S. Supreme Court that the Federal Circuit improperly "lowered the bar" for meeting the U.S. International Trade Commission's domestic industry requirement in patent disputes, by affir... (more story)
U.S. Patent and Trademark Office Director John Squires has instituted 10 more Patent Trial and Appeal Board petitions, largely in the pharmaceutical space.
A Delaware federal judge has denied a bid from medical equipment maker Kurin for a new trial after a jury found it owed Magnolia Medical $1.6 million for infringement of three patents covering blood culture co... (more story)
New Jersey Chief Technology Officer Kevin Dehmer has asked a state court judge to block TikTok from deposing him in the attorney general's consumer fraud lawsuit, arguing that he has no firsthand knowledge of ... (more story)
Eli Lilly failed to plausibly allege that a physician group and pharmacy conspired to falsely advertise compounded versions of its diabetes and weight loss drugs, but can continue with allegations they conspir... (more story)
Democratic federal lawmakers sent a letter to Florida Republican Gov. Ron DeSantis seeking more information on $10 million in misappropriated settlement funds, demanding answers to why the money was diverted t... (more story)
Tylenol maker Kenvue and several retailers have urged the Second Circuit to revisit its decision overturning a district court's exclusion of expert testimony for plaintiffs who claim prenatal exposure to the o... (more story)
CVS Health Corp. wants a second shot at dismissing a lawsuit accusing it of inflating its revenues through the use of artificial intelligence, arguing investors haven't shown it was using the technology to den... (more story)
The Eleventh Circuit's holding that the False Claims Act's provisions letting private individuals sue on the federal government's behalf pass muster under the U.S. Constitution may do little to halt the growin... (more story)
The U.S. Department of Labor's recent guidance on how to comply with federal laws requiring parity in health plan coverage between behavioral and physical healthcare provides critical new details on the agency... (more story)
Conduent Business Services LLC has reached a deal to resolve plaintiffs' claims in a proposed class action alleging it failed to adequately protect sensitive personal and health information of more than 44 mil... (more story)
The Eleventh Circuit upheld a $620,000 arbitration award in favor of an Indian teleradiology company against a radiology provider, finding the arbitrator did not exceed his authority by interpreting the partie... (more story)
A Colorado federal court Friday dropped an Austrian medical device-maker from a lawsuit brought by a podiatrist who alleged the company helped create a scheme to bill Medicare using improper codes, finding he ... (more story)
A medical training startup urged the Federal Circuit on Friday to revive claims accusing Galderma of a "classic catch-and-kill strategy" to derail what it says could have been a $100 million deal with Allergan... (more story)